Pawan Kumar Mudgil
About Pawan Kumar Mudgil
Data last updated:
Pawan Kumar Mudgil is a Director at Regen Biocorps Ahi Private Limited (since 2017), Director at Regen Nutripharm Private Limited (since 2016) and Director at Regen Phytozenika Private Limited (since 2020). The companies operate in Agriculture and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹13.99 Cr; the largest is Regen Biocorps Ahi Private Limited at ₹10.06 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Regen Biocorps Ahi Private Limited U74999GJ2017PTC095279 | Director | 25 Jan 2017 | 2017 | ₹10.06 Cr (FY 2024) | Active |
 Regen Nutripharm Private Limited U74900GJ2016PTC086399 | Director | 10 Mar 2016 | 2016 | ₹3.93 Cr (FY 2024) | Active |
| Regen Phytozenika Private Limited U51909GJ2020PTC116606 | Director | 17 Sep 2020 | 2020 | ₹4,536 (FY 2023) | Active |
Board colleagues of Pawan Kumar Mudgil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shephali Mudgil | 07417947 | Regen Biocorps Ahi Private Limited , Regen Nutripharm Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pawan Kumar Mudgil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pawan Kumar Mudgil
Pawan Kumar Mudgil currently holds 3 directorships: Regen Biocorps Ahi Private Limited (Director, since 25 Jan 2017, revenue ₹10.06 Cr (FY 2024)); Regen Nutripharm Private Limited (Director, since 10 Mar 2016, revenue ₹3.93 Cr (FY 2024)); Regen Phytozenika Private Limited (Director, since 17 Sep 2020, revenue ₹4,536 (FY 2023)).
Pawan Kumar Mudgil was first appointed on 10 Mar 2016 as Director at Regen Nutripharm Private Limited. The most recent appointment on record is 17 Sep 2020 at Regen Phytozenika Private Limited.
The 3 current companies of Pawan Kumar Mudgil that report revenue have a combined latest revenue of ₹13.99 Cr: Regen Biocorps Ahi Private Limited ₹10.06 Cr (FY 2024); Regen Nutripharm Private Limited ₹3.93 Cr (FY 2024); Regen Phytozenika Private Limited ₹4,536 (FY 2023).
The current boards of Pawan Kumar Mudgil's companies include Shephali Mudgil (Regen Biocorps Ahi Private Limited).